Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hillenbrand, Inc.
Hillenbrand, Inc. Reports Second Quarter Revenue of $191.4 Million, Up 5.6% Over Prior Year, and Confirms 2008 Earnings Guidance
June 1st, 2008
Hillenbrand, Inc. (NYSE:HI) reported second-quarter revenue of $191.4 million versus $181.2 million for the prior year's second quarter, up 5.6 percent. The increased revenue was favorably impacted by a more typical pneumonia and influenza season than we have experienced during the last several years and the ability of our sales and distribution organizations to capitalize on those conditions. Gross profit increased $3.2 million due to the increased sales with some unfavorable impact from higher health care expenses, direct fuel costs and fuel surcharges imposed by many of our suppliers. Second-quarter operating profit of $40.9 million includes the effects of one-time...
Source: Pharma Investments, Ventures & Law Weekly (2008-06-01)
|
